Fibrous Dysplasia Support Society - Charities report - 19.2

Fibrous Dysplasia Support Society - Charities report - 19.2


IRIS Accounts Production v19.3.0.619 Other Company accounts True False Pounds 1.4.18 31.3.19 31.3.19 FY Mrs H Wall Mrs H Wall FRS 102 Unaudited Large and medium-sized companies regime for accounts Full Charities SORP True True True False True False True iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure103362692018-03-31103362692019-03-31103362692018-04-012019-03-31103362692017-03-31103362692017-04-012018-03-31103362692018-03-3110336269ns0:CharitableCompanyLimitedByGuarantee2018-04-012019-03-3110336269ns15:PoundSterling2018-04-012019-03-3110336269ns0:Trustee42018-04-012019-03-3110336269ns11:FRS1022018-04-012019-03-3110336269ns11:AuditExempt-NoAccountantsReport2018-04-012019-03-3110336269ns11:LargeMedium-sizedCompaniesRegimeForAccounts2018-04-012019-03-3110336269ns11:FullAccounts2018-04-012019-03-3110336269ns11:CharitiesSORP2018-04-012019-03-3110336269ns16:EnglandWales2018-04-012019-03-3110336269ns11:RegisteredOffice2018-04-012019-03-3110336269ns0:Activity82018-04-012019-03-3110336269ns0:Activity82017-04-012018-03-311033626922018-04-012019-03-31
REGISTERED COMPANY NUMBER: 10336269 (England and Wales)
REGISTERED CHARITY NUMBER: 1175622















Report of the Trustees and
Financial Statements For The Year Ended 31 March 2019
for
Fibrous Dysplasia Support Society
(A Company Limited by Guarantee)

Fibrous Dysplasia Support Society
Contents of the Financial Statements
For The Year Ended 31 March 2019










Page

Report of the Trustees 1

Statement of Financial Activities 2

Balance Sheet 3

Notes to the Financial Statements 4 to 6


Fibrous Dysplasia Support Society
Report of the Trustees
For The Year Ended 31 March 2019
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with
the financial statements of the charity for the year ended 31 March 2019. The trustees have adopted the provisions of
Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)
(effective 1 January 2015).

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by
guarantee, as defined by the Companies Act 2006.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
10336269 (England and Wales)

Registered Charity number
1175622

Registered office
82 Nottingham Road
Somercotes
Alfreton
Derbyshire
DE55 4LY

Trustees
Mr K R Bittlestone - appointed 18/8/2016
Mrs S Burrell-Williams - appointed 18/8/2016 - resigned 3/3/2017
M N Cantwell - appointed 18/8/2016
Mrs H Delaney - appointed 18/8/2016
Mrs A Underhill - appointed 18/8/2016 - resigned 28/6/2017
Mrs H Wall - appointed 18/8/2016
Mr J Watson - appointed 18/8/2016

Approved by order of the board of trustees on 18 September 2019 and signed on its behalf by:



Mrs H Wall - Trustee

Fibrous Dysplasia Support Society
Statement of Financial Activities
For The Year Ended 31 March 2019
2019 2018

Unrestricted
fund
Total
funds
Notes £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 12,832 7,340
Total 12,832 7,340

EXPENDITURE ON
Charitable activities
Conference 2,925 6,175
NET INCOME 9,907 1,165
RECONCILIATION OF FUNDS

Total funds brought forward 14,462 13,297
TOTAL FUNDS CARRIED FORWARD 24,369 14,462

Fibrous Dysplasia Support Society
Balance Sheet
At 31 March 2019
2019 2018

Unrestricted
fund
Total
funds
Notes £    £   

CURRENT ASSETS
Cash at bank 24,369 14,462
NET CURRENT ASSETS 24,369 14,462
TOTAL ASSETS LESS CURRENT
LIABILITIES


24,369

14,462
NET ASSETS 24,369 14,462
FUNDS 4
Unrestricted funds 24,369 14,462
TOTAL FUNDS 24,369 14,462
The charitable company is entitled to exemption from audit under
Section 477 of the Companies Act 2006 for the year ended 31 March 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended
31 March 2019 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as
at the end of each financial year and of its surplus or deficit for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act
2006 relating to financial statements, so far as applicable to the charitable company.

These financial statements have been prepared in accordance with the provisions applicable to charitable companies
subject to the small companies regime.

The financial statements were approved by the Board of Trustees on 18 September 2019 and were signed on its behalf by:




Mrs H Wall -Trustee

Fibrous Dysplasia Support Society
Notes to the Financial Statements
For The Year Ended 31 March 2019
1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been
prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement
of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)',
Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of
Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost
convention.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it
is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the
charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and
the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has
been classified under headings that aggregate all cost related to the category. Where costs cannot be directly
attributed to particular headings they have been allocated to activities on a basis consistent with the use of
resources.

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions
arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2019 nor for the year ended
31 March 2018.

Trustees' expenses
There were no trustees' expenses paid for the year ended 31 March 2019 nor for the year ended 31 March 2018.

3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES


Unrestricted
fund
£   
INCOME AND ENDOWMENTS FROM
Donations and legacies 7,340
Total 7,340

EXPENDITURE ON
Charitable activities
Conference 6,175
Total 6,175

Fibrous Dysplasia Support Society
Notes to the Financial Statements - continued
For The Year Ended 31 March 2019
3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued

Unrestricted
fund
£   
NET INCOME 1,165
RECONCILIATION OF FUNDS

Total funds brought forward 13,297
TOTAL FUNDS CARRIED FORWARD 14,462

4. MOVEMENT IN FUNDS



At 1/4/18
Net movement
in funds

At 31/3/19
£    £    £   
Unrestricted funds
General fund 14,462 9,907 24,369

TOTAL FUNDS 14,462 9,907 24,369

Net movement in funds, included in the above are as follows:

Incoming
resources
Resources
expended
Movement in
funds
£    £    £   
Unrestricted funds
General fund 12,832 (2,925 ) 9,907

TOTAL FUNDS 12,832 (2,925 ) 9,907


Comparatives for movement in funds


At 1/4/17
Net movement
in funds

At 31/3/18
£    £    £   

Unrestricted Funds
General fund 13,297 1,165 14,462

TOTAL FUNDS 13,297 1,165 14,462

Fibrous Dysplasia Support Society
Notes to the Financial Statements - continued
For The Year Ended 31 March 2019
4. MOVEMENT IN FUNDS - continued

Comparative net movement in funds, included in the above are as follows:

Incoming
resources
Resources
expended
Movement in
funds
£    £    £   
Unrestricted funds
General fund 7,340 (6,175 ) 1,165

TOTAL FUNDS 7,340 (6,175 ) 1,165

A current year 12 months and prior year 12 months combined position is as follows:



At 1/4/17
Net movement
in funds

At 31/3/19
£    £    £   
Unrestricted funds
General fund 13,297 11,072 24,369
TOTAL FUNDS 13,297 11,072 24,369


A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming
resources
Resources
expended
Movement in
funds
£    £    £   
Unrestricted funds
General fund 20,172 (9,100 ) 11,072
TOTAL FUNDS 20,172 (9,100 ) 11,072
5. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2019.